Evidence map›Paper›PMID 33241776›Full record

ArticlePathogens and global health2021

Why are Asian countries outperforming the Western world in controlling COVID-19 pandemic?

Giovanni Landoni, Nicolò Maimeri, Monica Fedrizzi, Stefano Fresilli, Artem Kuzovlev, Valery Likhvantsev, Pasquale Nardelli, Alberto Zangrillo

Abstract read
In one paragraph

Article in Pathogens and global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Six-Month Quality of Life in COVID-19 Intensive Care Unit Survivors.Journal of cardiothoracic and vascular anesthesia · 2022
    Article
  8. Article
  9. Article
  10. Evolving trend change during the COVID-19 pandemic.Frontiers in public health · 2022
    Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giovanni LandoniDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute , Milan, Italy.ORCID 0000-0002-8594-5980
Nicolò MaimeriDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute , Milan, Italy.
Monica FedrizziDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute , Milan, Italy.
Stefano FresilliDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute , Milan, Italy.
Artem KuzovlevSchool of Medicine, Federal Research and Clinical Center of Resuscitation and Rehabilitation , Moscow, Russia.
Valery LikhvantsevSchool of Medicine, V. Negovsky Reanimatology Research Institute , Moscow, Russia.ORCID 0000-0002-5442-6950
Pasquale NardelliDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute , Milan, Italy.ORCID 0000-0003-0407-9871
Alberto ZangrilloDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute , Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 already caused more than 1,260,000 deaths around the world. However, mortality rates are not equal amongst the different countries. Mortality rates are ranging from less than 1 death per million in Taiwan, Vietnam and Thailand to 1,112 deaths per million in Belgium. In the present article, we report a striking difference in mean per million mortality between Asian and European countries (2.7 vs 197 deaths per million population, p < 0.001). In addition, we confirmed that the later a specific country was hit by the epidemic, the milder the impact on mortality during the first 50 days was. We analyzed several factors that may have contributed to this discrepancy including population age, previous experience of epidemics in the modern era, social acceptance of physical distancing and face masks, percentage of active smokers and lastly genetic prothrombotic mutations.

Indexed as

SARS-CoV-2AmericasAsiaCommunicable Disease ControlCOVID-19EuropeGlobal HealthHumansAmericaAsiaCOVID-19Europemortality ratepandemic

Identifiers

PMID33241776
PMCPMC7850376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.